Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Multicellular Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential
Victoria A Kriuchkovskaia, Ela K Eames, Sydney A McKee, et al.
Cancer Research
|
June 3, 2004
interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant)
Kerrie B Bouker, Todd C Skaar, David R Fernandez, et al.
Cancer Genetics and Cytogenetics
|
May 15, 2007
The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines
Kerrie B Bouker, Todd C Skaar, David S Harburger, et al.
Advanced Nanobiomed Research
|
April 2, 2026
Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential
Victoria A Kriuchkovskaia, Ela K Eames, Sydney A McKee, et al.
JCO Clinical Cancer Informatics
|
January 29, 2020
Evidence-Based Network Approach to Recommending Targeted Cancer Therapies
Jayaram Kancherla, Shruti Rao, Krithika Bhuvaneshwar, et al.
Bioinformatics (Oxford, England)
|
December 30, 2008
Differential dependency network analysis to identify condition-specific topological changes in biological networks
Bai Zhang, Huai Li, Rebecca B Riggins, et al.
Carcinogenesis
|
May 10, 2005
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis
Kerrie B Bouker, Todd C Skaar, Rebecca B Riggins, et al.
Breast Cancer Research : BCR
|
September 6, 2018
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
Tian Du, Matthew J Sikora, Kevin M Levine, et al.
Endocrinology
|
October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 2, 2019
Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma
Deanna M Tiek, Subreen A Khatib, Colin J Trepicchio, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Multicellular Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential
Victoria A Kriuchkovskaia, Ela K Eames, Sydney A McKee, et al.
Cancer Research
|
June 3, 2004
interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant)
Kerrie B Bouker, Todd C Skaar, David R Fernandez, et al.
Cancer Genetics and Cytogenetics
|
May 15, 2007
The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines
Kerrie B Bouker, Todd C Skaar, David S Harburger, et al.
Advanced Nanobiomed Research
|
April 2, 2026
Heterogenous Model of Temozolomide Resistance in Glioblastoma Reveals Phenotypic Shifts in Drug Response and Migratory Potential
Victoria A Kriuchkovskaia, Ela K Eames, Sydney A McKee, et al.
JCO Clinical Cancer Informatics
|
January 29, 2020
Evidence-Based Network Approach to Recommending Targeted Cancer Therapies
Jayaram Kancherla, Shruti Rao, Krithika Bhuvaneshwar, et al.
Bioinformatics (Oxford, England)
|
December 30, 2008
Differential dependency network analysis to identify condition-specific topological changes in biological networks
Bai Zhang, Huai Li, Rebecca B Riggins, et al.
Carcinogenesis
|
May 10, 2005
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis
Kerrie B Bouker, Todd C Skaar, Rebecca B Riggins, et al.
Breast Cancer Research : BCR
|
September 6, 2018
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
Tian Du, Matthew J Sikora, Kevin M Levine, et al.
Endocrinology
|
October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
Shaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 2, 2019
Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma
Deanna M Tiek, Subreen A Khatib, Colin J Trepicchio, et al.
Page
of 8